Mabtech
Fredrik Lyon has extensive experience in marketing and operations management. Fredrik started their career at Kabi Pharmacia in 1993 as a consultant and then moved on to Pharmacia & Upjohn in 1994, where they served as a Sales and Purchasing Manager. In 1997, Lyon joined Diapharma as a Marketing and Business Development Manager. In 2001, they joined Mabtech, Inc as the Vice President of Marketing and Operations and was later promoted to President in 2017. At Mabtech, Lyon focused on marketing monoclonal antibodies and kits to researchers monitoring immune responses. Fredrik also oversaw the operations of the company's US subsidiary.
Fredrik Lyon earned their B.A. in Economics from Indiana University Bloomington in 1985. Fredrik later completed their M.B.A. in Finance & International Business from Xavier University - Williams College of Business between 1991 and 1993.
This person is not in the org chart
This person is not in any offices
Mabtech
We are a Swedish biotech company developing immunoassays for life science research. Our goal is to aid research, by providing the scientific community with innovative tools, in particular for ELISpot, FluoroSpot, and ELISA. To that end, we develop and produce a wide range of monoclonal antibodies, kits, peptide pools, and instruments for in vitro applications. We started off in Stockholm, Sweden in 1986, and our headquarter still lies in Nacka Strand, just east of the inner city. We do everything here, from research and production, to finance, IT, quality control, marketing, distribution, and sales. In addition, we have a sales office in Cincinnati, Ohio, and collaborate with great distributors around the globe. The quality of our products really comes down to our entire organization; the balance between individual action and care for the collective. Because for us, quality isn’t just a word. It’s a mindset, a mantra, and a lens we hold to all our initiatives, whatever the size. Being part of the whole scientific community, we want to do our share in helping science progress. So please see us as peer – feel free to strike up any sort of conversation with us.